The global nootropic products market was valued at USD 39.0 billion in 2021 and is projected to expand at a CAGR of 10.5% from 2022 to 2030. Nootropics are cognitive enhancers that have become increasingly popular as a way to improve focus, creativity, and mental energy in people of all ages. The global nootropic products market is driven by the rising demand for these products from students, corporate professionals, and gamers. Furthermore, the growing health-conscious population and the increasing prevalence of mental health disorders such as depression, stress, and anxiety are expected to drive the demand for nootropics.

The growing popularity of nootropics has led to the development of a wide variety of products for different target groups. For instance, in January 2021, BrainMD launched Adder-C, a nootropic specifically designed for people who are looking for a more natural approach to improving their mental performance. The product has been formulated with natural herbs, vitamins, and minerals to support mental clarity, focus, and energy. Furthermore, the product is non-addictive and free from any stimulants.

In addition, the increasing use of nootropics in the medical field is also expected to propel the market growth. Nootropics are increasingly being used to treat cognitive decline, dementia, and Alzheimer’s disease. For instance, in November 2020, Neurohacker Collective developed Qualia Mind Nootropic, a product specifically designed to support cognitive performance. The product uses 28 active ingredients, including nootropics, vitamins, and minerals, to support mental clarity, focus, and energy.

The increasing popularity of e-commerce channels is also expected to drive the nootropic products market. Key players are increasingly focusing on selling their products through e-commerce platforms, as it allows them to reach a wider customer base. Furthermore, the availability of discounted products on these platforms is further expected to accelerate the market growth. For instance, in June 2021, Nootrico launched its range of nootropic products on Amazon. The company has launched a variety of products including MindBoost Day, MindBoost Night, and MindBoost Focus, each with a unique blend of natural ingredients and vitamins.

Furthermore, players are increasingly focusing on the development of new products to gain a competitive edge in the market. For instance, in August 2020, Nootropics Depot launched a new product, Alpha GPC, to meet the increasing demand for cognitive enhancers. Alpha GPC is a natural nootropic that helps enhance cognitive performance and memory. The product is said to be safe, natural, and non-addictive.

The cognitive enhancers segment led the market and accounted for a share of around 30.2% in 2022. The rise in demand for cognitive enhancers is attributed to the increasing prevalence of neurodegenerative disorders, such as Alzheimer’s disease, dementia, and Parkinson’s disease. According to a survey published by the World Health Organization, in January 2020, the prevalence of neurodegenerative disorders among adults aged between 20-80 years was reported to be around 6.6%. Furthermore, the growing use of nootropics to improve physical and mental performance is also driving the market growth.

The energy boosters segment is anticipated to expand at the fastest CAGR of 9.1% over the forecast period. The increasing demand for energy boosters is attributed to the rising prevalence of chronic fatigue and the growing demand for natural and organic energy supplements. According to an article published by the National Institutes of Health, in October 2019, chronic fatigue syndrome is a common disorder that affects 836,000 to 2.5 million people in the United States. Furthermore, the growing preference for dietary supplements to enhance physical and mental performance is also driving the market growth.

The pharmacies and drug stores segment held the major share of over 48.4% in 2022 and is anticipated to register the highest CAGR of 12.3% during the forecast period. Easy availability of nootropics products through pharmacies & drug stores is one of the major reasons for the segment’s strong market position. Nootropic drugs are widely available in pharmacies and drug stores without a prescription, as these products are non-prescription drugs. For instance, in 2019, The Vitamin Shoppe launched a nootropic called Brain Health Advanced, which is available in all its stores across the U.S.

Online distribution channels such as e-commerce sites and direct-to-consumer (D2C) platforms are gaining traction as they offer convenience to customers. According to a study by the National Institute of Mental Health in 2020, around 35% of adults in the U.S. prefer to purchase nootropics online. Online stores offer a variety of products, exclusive deals, discounts, and a wide range of purchasing options. Additionally, customers can read reviews and compare prices of the same product before making a purchase.

The prescription segment accounted for the largest revenue share of 69.3% in the year 2022. Increasing awareness about mental health among consumers and the rising use of nootropics as an alternative therapy for treating mental disorders such as ADHD and depression are key factors driving the segment. Additionally, the increasing number of prescriptions from healthcare professionals and the rising demand for products with higher effectiveness are further propelling the segment. For instance, in April 2021, Neurohacker Collective, a nootropics company, launched its first prescription product, Qualia Nootropic Formulary, for the treatment of ADHD, depression, and anxiety.

The non-prescription segment is projected to expand at the fastest CAGR of 13.7% during the forecast period. The increasing availability of nootropics in online stores and the increasing number of health-conscious people who prefer to use non-prescription nootropics are the key factors driving the segment. Furthermore, the rising number of collaborations between supplement and nootropics companies and online stores such as Amazon and GNC has made these products easily accessible. For instance, in January 2021, Nootrobox, a company that sells nootropic supplements, partnered with Amazon to make its products available on Amazon’s platform.

North America held the largest share in the global nootropics products market in 2021 and is expected to exhibit the highest CAGR during the forecast period. The increasing prevalence of cognitive diseases such as Alzheimer’s and Parkinson’s and the growing demand for cognitive enhancement supplements in the region are the major factors driving the growth of the market in this region. For instance, in April 2021, Neurohacker Collective, a U.S.-based health and wellness company, launched a new cognitive supplement called Eternus, which is designed to provide long-term cognitive support.

Asia Pacific is expected to witness the fastest growth in the market during the forecast period. The increasing demand for cognitive enhancement supplements and the rising prevalence of cognitive disorders are the key factors driving the growth of the market in this region. For instance, in December 2020, Nootropics Depot, a U.S.-based nootropics supplier, opened its first office in India to cater to the growing demand for nootropics supplements in the region.

In this part of the nootropics products business plan we will provide a detailed breakdown of all income and expense categories of the business. These forecasts include cash flow projections and capital requirements. Usually, these projections are drafted for a 5-year period.

Revenue Assumptions
The main source of revenues for a nootropics products business comes from selling nootropic supplements, nootropic stacks, and other related products. Revenues could also be generated from affiliate marketing and advertising.

Projecting Expenses
In this section, all the regular expenses related to keeping the nootropics products business running will be described. The list of operating expenses includes purchasing of raw materials, wages, maintenance and repairs, utilities, insurance policies, advertising, and others. Additionally, you must also consider costs associated with acquiring and maintaining shelf space in retail stores and distribution channels.

Some of the key companies operating in the nootropics market are increasingly focusing on product launches and expansion of the distribution channel to gain prominent visibility among consumers. Some of the initiatives are:

– In June 2022, Nootrobox launched a range of cognitive enhancers specifically formulated to improve mental clarity, focus, and memory.

– In August 2022, NootropicX launched a range of natural nootropic supplements designed to boost energy levels and cognitive performance.

– In October 2022, Nootrico launched a range of nootropic supplements designed to improve focus and concentration.

Some of the prominent players in the nootropics market include:

– Nootrobox
– NootropicX
– Nootrico
– Brainz
– Nutraceuticals International Group
– Nootropics Depot
– Pure Nootropics
– Nootropics City
– Nootropics.com
– Nootropic Nation

This report forecasts growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2017 to 2030. For this study, Grand View Research has segmented the global nootropics products market based on product, distribution channel, type, and region:

1. Product Outlook (Revenue, USD Million, 2017 – 2030)

– Memory Enhancers
– Cognitive Enhancers
– Mood Enhancers
– Others

2. Distribution Channel Outlook (Revenue, USD Million, 2017 – 2030)

– Supermarkets & Hypermarkets
– Online
– Others

3. Type Outlook (Revenue, USD Million, 2017 – 2030)

– Natural
– Synthetic

4. Regional Outlook (Revenue, USD Million, 2017 – 2030)

– North America
– Europe
– Asia Pacific
– Central & South America
– Middle East & Africa

[Q]: What are the Factors Driving the Nootropics Products Market?
[A]: Increasing consumer awareness regarding the advantages of nootropics, increasing demand for cognitive enhancement, increasing use of nootropics in the consumer market, and the emergence of an online nootropics industry are some of the factors driving the global nootropics products market.

[Q]: Who are the Key Players in the Nootropics Products Market?
[A]: Major players in the global nootropics products market include Nootrobox, Nootropics Depot, Pure Nootropics, Neurohacker Collective, Natural Stacks, Peak Nootropics, and Mind Nutrition.

[Q]: What are the Benefits of Nootropics?
[A]: Nootropics are known to have many benefits, such as improved mental focus and concentration, improved memory, improved cognitive performance, improved brain health, and improved mood.

[Q]: What are the Different Types of Nootropics?
[A]: Nootropics can be divided into several categories, including synthetic nootropics, natural nootropics, and racetams. Synthetic nootropics include drugs such as Piracetam, Aniracetam, and Oxiracetam, while natural nootropics include herbs and supplements such as Ginkgo biloba, Bacopa monnieri, and Rhodiola rosea. Racetams are a class of synthetic compounds that have properties similar to those of the natural nootropics.

[Q]: What is the Potential of Product Innovation in the Nootropics Products Market?
[A]: The global nootropics market is highly competitive, and manufacturers are focusing on product innovation and development in order to gain a competitive edge. Manufacturers are introducing new and innovative products with higher efficacy and improved safety profiles. They are also launching products with additional functionalities, such as sleep-tracking and stress-reduction capabilities. These initiatives are likely to stimulate market growth over the forecast period.